The Effect of Anticancer Nanotherapy on Lewis Lung Carcinoma
Orel V.E., Shevchenko A.D., Nikolov N.A., Dzyatkovskya N.N., Romanov A.V., Richalskiy A.Yu., Burlaka A.P., Lukin S.M., Uvarov V.N., Schepotin I.B., National Cancer Institute, UA
Introduction. Current forms of antitumor anthracycline antibiotic doxorubicin (DOXO) are highly toxic to the patient and can cause systematic complications, most notably cardiotoxicity. Systemic toxicity can seriously decrease the effectiveness of the drug since a [...]